Free CE/CMEVideo

25th Annual International Congress on the Future of Breast Cancer® West

Release Date

July 31, 2026

Expiration Date

September 1, 2026

Credits

13.0 CME, NCPD

Activity Overview

The 25th Annual International Congress on the Future of Breast Cancer® West provides clinicians with cutting-edge updates on recent advances in the treatment of breast cancer, from preclinical breakthroughs to changes in clinical treatment paradigms. Novel agents and improved regimens, coupled with more in-depth molecular and phenotypic subtyping, are driving the future of breast cancer therapy. This dynamic program focuses on the practical implications of emerging data for patient care in the clinic. Recent data and their clinical impact are highlighted throughout the program, with expert perspectives on how to apply the evidence to individualize therapy for patients with breast cancer. Current areas of controversy or uncertainty are also debated, with discussions of ongoing clinical trials and investigational approaches designed to address these questions.

This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other health care professionals to learn from international leaders in the field of breast cancer to increase knowledge, apply new data to practice, and, ultimately, improve patient outcomes.

This educational activity is an archive of the live presentation held on July 17-18, 2026.

Target Audience

This educational activity is intended for medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer may also participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Integrate genomic and molecular biomarker findings into individualized treatment strategies for patients with early-stage and metastatic breast cancer
  • Formulate multidisciplinary locoregional management strategies incorporating contemporary imaging, surgical, and radiation approaches
  • Evaluate emerging data from key clinical trials and their implications for the management of early-stage and advanced/metastatic breast cancer
  • Apply current evidence and guideline recommendations to develop stage-specific, personalized treatment plans for patients with breast cancer
  • Implement evidence-based strategies to prevent and manage treatment-related adverse events in breast cancer care
25th Annual International Congress on the Future of Breast Cancer® West

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 13.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 13.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Exact Sciences Corporation; Hologic, Inc; Novartis Pharmaceuticals Corporation; Puma Biotechnology, Inc; Stemline Therapeutics, Inc; and Tolmar Pharmaceuticals.

Follow Us on Social Media!

Course

25th Annual International Congress on the Future of Breast Cancer® West

Create Account